ADIPOQ |
Q15848
|
adiponectin, C1Q and collagen domain containing
|
|
4.6E-09 |
0.376 |
0.885 |
AIC |
|
Aicardi syndrome
|
|
|
0.729 |
0.462 |
ALK |
Q9UM73
|
ALK receptor tyrosine kinase
|
Kinase
|
3.2E-06 |
0.396 |
0.846 |
ATM |
Q13315
|
ATM serine/threonine kinase
|
Kinase
|
5.6E-47 |
0.374 |
0.885 |
AMFR |
Q9UKV5
|
autocrine motility factor receptor
|
|
5.8E-05 |
0.599 |
0.692 |
BRAF |
P15056
|
B-Raf proto-oncogene, serine/threonine kinase
|
Kinase
|
1.00 |
0.319 |
0.846 |
CRP |
P02741
|
C-reactive protein
|
|
3.7E-03 |
0.299 |
0.962 |
CXCL8 |
P10145
|
C-X-C motif chemokine ligand 8
|
Signaling
|
2.7E-04 |
0.310 |
0.962 |
CALCA |
P01258 P06881
|
calcitonin related polypeptide alpha
|
Signaling
|
1.6E-02 |
0.416 |
0.923 |
CASZ1 |
Q86V15
|
castor zinc finger 1
|
Transcription factor
|
1.00 |
0.553 |
0.731 |
CAV1 |
Q03135
|
caveolin 1
|
Enzyme modulator
|
8.3E-03 |
0.388 |
0.885 |
CD274 |
Q9NZQ7
|
CD274 molecule
|
Receptor
|
1.9E-02 |
0.324 |
0.923 |
CD44 |
P16070
|
CD44 molecule (Indian blood group)
|
|
2.4E-07 |
0.363 |
0.962 |
F9 |
P00740
|
coagulation factor IX
|
Enzyme
|
1.00 |
0.465 |
0.885 |
CCDC6 |
Q16204
|
coiled-coil domain containing 6
|
|
0.58 |
0.517 |
0.808 |
CDKN1C |
P49918
|
cyclin dependent kinase inhibitor 1C
|
|
0.82 |
0.456 |
0.846 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
CYP2R1 |
Q6VVX0
|
cytochrome P450 family 2 subfamily R member 1
|
|
3.8E-10 |
0.563 |
0.731 |
CYP24A1 |
Q07973
|
cytochrome P450 family 24 subfamily A member 1
|
Enzyme
|
3.2E-23 |
0.518 |
0.692 |
CYP27B1 |
O15528
|
cytochrome P450 family 27 subfamily B member 1
|
Enzyme
|
1.9E-07 |
0.502 |
0.769 |
DIRC3 |
|
disrupted in renal carcinoma 3
|
|
3.4E-07 |
0.780 |
0.308 |
ELN |
P15502
|
elastin
|
|
2.1E-14 |
0.415 |
0.885 |
EFNB2 |
P52799
|
ephrin B2
|
Signaling
|
0.99 |
0.561 |
0.692 |
EGFR |
P00533
|
epidermal growth factor receptor
|
Kinase
|
0.37 |
0.295 |
0.885 |
ERBB2 |
P04626
|
erb-b2 receptor tyrosine kinase 2
|
Kinase
|
6.0E-03 |
0.328 |
0.923 |